In the latest close session, Cardinal Health (CAH) saw a 1.93% increase to $202.95, outperforming the S&P 500. However, the stock has fallen by 4.23% in the past month, lagging behind the Medical sector and S&P 500 gains.

Analysts predict Cardinal Health will report an EPS of $2.31 and revenue of $64.07 billion, showing a positive trend. The Zacks Rank system rates the stock as a #3 (Hold) currently, with potential for future growth based on analyst estimate revisions.

Cardinal Health’s valuation includes a Forward P/E ratio of 20.19, higher than the industry average. The stock also has a PEG ratio of 1.45 compared to the industry’s average of 2.36. Investors should monitor industry trends and the company’s performance closely.

Zacks’ Research Chief has identified a stock with the potential to double in value, surpassing previous recommendations like Hims & Hers Health. For more insights and recommendations, visit Zacks Investment Research for the latest analyses and updates on Cardinal Health and other stocks.

Read more at Nasdaq: Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know